-
1
-
-
14644412849
-
Pre-eclampsia
-
DOI 10.1016/S0140-6736(05)17987-2
-
Sibai BM, Dekker G., Kupferminc M. Pre-eclampsia. Lancet. 2005 ; 365: 785-799. (Pubitemid 40311367)
-
(2005)
Lancet
, vol.365
, Issue.9461
, pp. 785-799
-
-
Sibai, B.1
Dekker, G.2
Kupferminc, M.3
-
2
-
-
0025909958
-
Placental bed spiral arteries in the hypertensive disorders of pregnancy
-
Pijinenborg R., Anthony J., Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynecol. 1991 ; 98: 648-655.
-
(1991)
Br J Obstet Gynecol
, vol.98
, pp. 648-655
-
-
Pijinenborg, R.1
Anthony, J.2
Davey, D.A.3
-
3
-
-
0030795124
-
Plasma thrombomodulin level in very low birthweight infants at birth
-
Nako Y., Ohki Y., Harigaya A., Tamomasa T., Morikawa A. Plasma thrombomodulin level in very low birthweight infants at birth. Acta Paediatr. 1997 ; 86: 1105-1109. (Pubitemid 27443720)
-
(1997)
Acta Paediatrica, International Journal of Paediatrics
, vol.86
, Issue.10
, pp. 1105-1109
-
-
Nako, Y.1
Ohki, Y.2
Harigaya, A.3
Tomomasa, T.4
Morikawa, A.5
-
4
-
-
0020063793
-
Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of Protein C
-
Esmon CT, Esmon NL, Haris KW Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of Protein C. J Biol Chem. 1982 ; 257: 7944-7947.
-
(1982)
J Biol Chem
, vol.257
, pp. 7944-7947
-
-
Esmon, C.T.1
Esmon, N.L.2
Haris, K.W.3
-
5
-
-
0030297074
-
Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia
-
DOI 10.1016/S0020-7292(96)02755-5, PII S0020729296027555
-
Shaarawy M., Didy HE Thrombomodulin plasminogen activator inhibitor type 1(PAI-I) and fibronectin as a biomarkers of endothelial damage in preeclampsia and eclampsia. Int J Gynaecol Obstet. 1996 ; 55: 135-139. (Pubitemid 26383740)
-
(1996)
International Journal of Gynecology and Obstetrics
, vol.55
, Issue.2
, pp. 135-139
-
-
Shaarawy, M.1
El Didy, H.2
-
6
-
-
0029060606
-
Maternal level thrombomodulin is increased in mild preeclampsia
-
Bontis J., Vavilis D., Agorasros T., Zournatzi V., Konstantinidis T., Tagou K. Maternal level thrombomodulin is increased in mild preeclampsia. Eur J Obstet Gynecol Reprod Biol. 1995 ; 60: 139-141.
-
(1995)
Eur J Obstet Gynecol Reprod Biol
, vol.60
, pp. 139-141
-
-
Bontis, J.1
Vavilis, D.2
Agorasros, T.3
Zournatzi, V.4
Konstantinidis, T.5
Tagou, K.6
-
7
-
-
0343618584
-
Kratachvilova. Thrombomodulin as a marker of endothelium damage in some clinical conditions
-
Remkova A., Kovacova E., Prikazka M., Kratachvilova. Thrombomodulin as a marker of endothelium damage in some clinical conditions. Eur J Int Med. 2000 ; 11: 79-84.
-
(2000)
Eur J Int Med
, vol.11
, pp. 79-84
-
-
Remkova, A.1
Kovacova, E.2
Prikazka, M.3
-
9
-
-
0037393051
-
Hemostasis during normal pregnancy and puerperium
-
Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003 ; 29: 125-130.
-
(2003)
Semin Thromb Hemost
, vol.29
, pp. 125-130
-
-
Hellgren, M.1
-
10
-
-
37549055121
-
Correlation between thrombomodulin and severe preeclampsia: A summary
-
Wiwanitkit V. Correlation between thrombomodulin and severe preeclampsia: a summary. Clin Appl Thromb Hemost. 2008 ; 14: 99-101.
-
(2008)
Clin Appl Thromb Hemost
, vol.14
, pp. 99-101
-
-
Wiwanitkit, V.1
-
11
-
-
64549098551
-
C. Serum thrombomoduline levels could be a useful parameter to determine the severity of preeclampsia and prognosis
-
Altunsoy S., stün C. Serum thrombomoduline levels could be a useful parameter to determine the severity of preeclampsia and prognosis. Turkiye Klinikleri J Gynecol. 1996 ; 6: 39-41.
-
(1996)
Turkiye Klinikleri J Gynecol
, vol.6
, pp. 39-41
-
-
Altunsoy, S.1
-
13
-
-
0036719075
-
The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by supressing adhesion molecule expression via nuclear factor kappa B and mitogen-activated protein kinase pathways
-
Conway EM, Van de Wouwer M., Pollefeyt S., et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by supressing adhesion molecule expression via nuclear factor kappa B and mitogen-activated protein kinase pathways. J Exp Med. 2002 ; 196: 565-577.
-
(2002)
J Exp Med
, vol.196
, pp. 565-577
-
-
Conway, E.M.1
Van De Wouwer, M.2
Pollefeyt, S.3
|